Pharma Strategy Blog

Exciting times in CLL: an ASCO 2013 interview with Dr Susan O’Brien

MaverickNY — Mon, 10 Jun 2013 19:14:37 +0000

At the recent ASCO 2013 meeting in Chicago, I had the great pleasure to interview Susan M. O’Brien, MD who…

MaverickNY — Tue, 28 May 2013 14:42:35 +0000

It’s that time of the year when the annual meeting of the American Society of Clinical Oncology (ASCO) hurtles around…

MaverickNY — Thu, 16 May 2013 18:30:45 +0000

One of the hot topics at this year’s annual ASCO meeting is clearly going to be PD-1 and PD-L1 immunotherapies,…

MaverickNY — Mon, 22 Apr 2013 14:10:59 +0000

Continuing my series of posts about the 2013 annual meeting of the American Association for Cancer Research (AACR), I am delighted…

MaverickNY — Wed, 17 Apr 2013 16:39:45 +0000

On the final day of the annual 2013 meeting of the American Association for Cancer Research (AACR) in Washington DC,…

MaverickNY — Mon, 15 Apr 2013 18:57:38 +0000

One of the interesting themes for that emerged for me at AACR this year was the amount of effort that…

MaverickNY — Thu, 11 Apr 2013 16:29:11 +0000

This year’s American Association for Cancer Research (AACR) annual meeting grew by 8% to approximately 18,000 attendees with 25% from…

MaverickNY — Tue, 26 Mar 2013 15:50:01 +0000

Soft tissue sarcomas (STS) are relatively rare and represent about 1% of all solid tumours. There are more than 50…

MaverickNY — Wed, 20 Mar 2013 17:32:47 +0000

Patient advocacy is something I care about and spend time actively supporting two worthwhile causes, including the lovely folks at…

MaverickNY — Mon, 11 Mar 2013 17:49:48 +0000

One of the interesting things about basic cancer research is that new targets emerge all the time, offering fresh opportunities…